prostate cancer

May 24, 2022 · ASCO Staff
At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider. Read More >>
February 14, 2022 · Brielle Gregory Collins, ASCO staff
Research from ASCO’s 2022 Genitourinary Cancers Symposium features a study on predicting the risk of developing and dying from metastatic prostate cancer in a diverse population. Read More >>
January 25, 2022 · James E. Williams, Jr.
In this “Voices on Cancer” post, prostate cancer survivor James E. Williams, Jr., shares how his experience with prostate cancer led him to understand the importance of patient advocacy and inspired him to get involved in bringing awareness to the disease. Read More >>
June 23, 2021 · Brielle Gregory Collins, ASCO staff
In this webinar, experts discuss new research in genitourinary cancers presented at the 2021 ASCO Annual Meeting and the 2021 Genitourinary Cancers Symposium that highlighted advances in treating prostate, bladder, kidney, and testicular cancers. Read More >>
2021 ASCO Annual Meeting; #ASCO21
June 3, 2021 · ASCO Staff
The ASCO Annual Meeting begins on June 4, and here is some of the notable research that will be presented. Topics include combined immunotherapy for esophageal cancer, targeted radiation for mCRPC, olaparib for HER2-negative breast cancer, adjuvant chemotherapy for cervical cancer, pembrolizumab for kidney cancer, and toripalimab for nasopharyngeal cancer. Read More >>

Pages